Published in Br J Dermatol on February 01, 2006
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J (2009) 3.93
Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol (2008) 2.25
Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference. Int J Mol Sci (2017) 1.38
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res (2006) 1.03
Association between Psoriasis and Cardiovascular Risk Factors in Korean Patients. Ann Dermatol (2010) 0.97
Genetics of psoriasis and pharmacogenetics of biological drugs. Autoimmune Dis (2013) 0.92
Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis. Dis Markers (2014) 0.81
Molecular genetics of Psoriasis (Principles, technology, gene location, genetic polymorphism and gene expression). Int J Health Sci (Qassim) (2010) 0.79
Lipid disturbances in psoriasis: an update. Mediators Inflamm (2010) 0.77
Pentoxifylline and its applications in dermatology. Indian Dermatol Online J (2014) 0.75
Cardiovascular risk in psoriasis: a population-based analysis with assessment of the framingham risk score. Scientifica (Cairo) (2013) 0.75
Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma. Oxid Med Cell Longev (2015) 0.75
Metabolic Syndrome in Psoriasis among Urban South Indians: A Case Control Study Using SAM-NCEP Criteria. J Clin Diagn Res (2017) 0.75
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature. Mol Diagn Ther (2017) 0.75
Is type II diabetes mellitus a disease of the innate immune system? Diabetologia (1998) 5.43
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol (2009) 4.12
Effect of atorvastatin on plasma fibrinogen. Lancet (1998) 3.35
Involving the urban poor in health services through accommodation--the employment of neighborhood representatives. Am J Public Health Nations Health (1967) 3.29
British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol (2005) 3.10
Staging of twin-twin transfusion syndrome. J Perinatol (1999) 2.67
Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis (2005) 2.61
Radioimmunoassay of leptin in human plasma. Clin Chem (1996) 2.61
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut (2005) 2.36
Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res (2000) 2.28
Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]. Br J Dermatol (2009) 2.25
Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol (2013) 2.11
Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study. Br J Dermatol (2013) 2.10
A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis. Br J Dermatol (2010) 2.04
Tinea nigra secondary to Exophiala werneckii responding to itraconazole. Br J Dermatol (1997) 1.91
Potent topical steroid obtained from a Chinese herbalist. Br J Dermatol (1992) 1.87
Guidelines for credentialing and granting privileges for endoscopic ultrasound. Gastrointest Endosc (2001) 1.81
Visual loss as a complication of spine surgery. A review of 37 cases. Spine (Phila Pa 1976) (1997) 1.75
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol (2005) 1.72
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol (2005) 1.67
A non-HLA gene within the MHC in psoriasis. Lancet (1999) 1.67
Interrater agreement among psychiatrist in psychiatric emergency assessments. Am J Psychiatry (1998) 1.63
A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis. Br J Dermatol (2010) 1.61
Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab. Br J Dermatol (2004) 1.61
Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res (2010) 1.60
Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol (2002) 1.59
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol (2014) 1.57
Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol (1991) 1.57
Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study. Br J Dermatol (2009) 1.51
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia (1994) 1.50
Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study. Br J Dermatol (2009) 1.50
Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Br J Dermatol (2005) 1.49
Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis (2007) 1.47
Acute suppurative ringworm (kerion) caused by Trichophyton rubrum. Br J Dermatol (1999) 1.44
Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet (2007) 1.44
DRESS syndrome caused by efalizumab. Clin Exp Dermatol (2007) 1.42
Selective photocoagulation of communicating vessels in the treatment of monochorionic twins with selective growth retardation. Am J Obstet Gynecol (2001) 1.41
Hyperferritinaemia; laboratory implications. Ann Clin Biochem (2012) 1.41
Presenile Alzheimer disease: amyloid plaques in the cerebellum. Neurology (1980) 1.41
Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. Br J Dermatol (2005) 1.40
Preliminary results of bedside inferior vena cava filter placement: safe and cost-effective. Chest (1998) 1.40
Geographical ancestry is a key determinant of epidermal morphology and dermal composition. Br J Dermatol (2014) 1.40
Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemia. Int J Clin Pract (1999) 1.39
The Effects of Injection of Antitoxic and Antibacterial Sera on the Opsonic Power of the Blood. Biochem J (1906) 1.39
Providing lifestyle behaviour change support for patients with psoriasis: an assessment of the existing training competencies across medical and nursing health professionals. Br J Dermatol (2014) 1.39
Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study. Br J Dermatol (2012) 1.39
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia. Atherosclerosis (2000) 1.39
Making a 'point' about the safe disposal of sharps in patients on biological therapies. Br J Dermatol (2008) 1.37
Stabilization of blood glucose by cooling with ice: an effective procedure for preservation of samples from adults and newborns. Clin Chem (1976) 1.37
Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. J Neurol Neurosurg Psychiatry (2002) 1.36
A validation study of multicenter diffusion tensor imaging: reliability of fractional anisotropy and diffusivity values. AJNR Am J Neuroradiol (2011) 1.32
Guidelines for the management of tinea capitis. British Association of Dermatologists. Br J Dermatol (2000) 1.31
A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol (2002) 1.27
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol (2013) 1.26
Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol (2008) 1.26
Recognition of need in health care consultations: a qualitative study of people with psoriasis. Br J Dermatol (2012) 1.23
Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet (2001) 1.23
The effect of in vivo interferon-gamma on the distribution of LFA-1 and ICAM-1 in normal human skin. J Invest Dermatol (1989) 1.22
Routine early endoscopy in upper-gastrointestinal-tract bleeding: a randomized, controlled trial. N Engl J Med (1981) 1.22
Characterization of a microvillous membrane preparation from human placental syncytiotrophoblast: a morphologic, biochemical, and physiologic, study. Am J Obstet Gynecol (1977) 1.20
Hypoxia reduces expression and function of system A amino acid transporters in cultured term human trophoblasts. Am J Physiol Cell Physiol (2002) 1.20
A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease. J Cardiovasc Risk (2000) 1.18
Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol (2003) 1.17
Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr (1967) 1.17
Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. Br J Dermatol (2011) 1.16
Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol (2001) 1.16
Ascertainment of maternal deaths in New York City. Am J Public Health (1991) 1.14
The Arterial Supply of the Distal Colon Pertinent to Abdominoperineal Proctosigmoidectomy, with Preservation of the Sphincter Mechanism. Ann Surg (1948) 1.14
Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol (2013) 1.14
Diffuse esophageal glycogenic acanthosis: an endoscopic marker of Cowden's disease. Am J Gastroenterol (1997) 1.14
Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis (2007) 1.13
A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13
Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun (2009) 1.12
The role of neuropeptides in psoriasis. Br J Dermatol (2006) 1.12
Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol (2005) 1.11
Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol (2006) 1.11
Inpatient management of psoriasis: a multicentre service review to establish national admission standards. Br J Dermatol (2007) 1.10
Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res (2002) 1.09
Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev (2006) 1.09
Neutral amino acid transport systems of microvillous membrane of human placenta. Am J Physiol (1988) 1.08
Striae gravidarum in primiparae. Br J Dermatol (2006) 1.08
Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. Br J Dermatol (1997) 1.08
Blood glucose and glycated haemoglobin measurement in hospital: which method? Diabet Med (1993) 1.07